Holen Sie sich die Stockscreener-App
2.58
2.64%
-0.07
Handel nachbörslich:
2.54
-0.04
-1.55%
Schlusskurs vom Vortag:
$2.65
Offen:
$2.68
24-Stunden-Volumen:
251.86K
Relative Volume:
0.94
Marktkapitalisierung:
$126.99M
Einnahmen:
$596.60K
Nettoeinkommen (Verlust:
$-11.72M
KGV:
-10.81
EPS:
-0.2386
Netto-Cashflow:
$-9.51M
1W Leistung:
-22.29%
1M Leistung:
+64.33%
6M Leistung:
+76.71%
1J Leistung:
+108.06%
1-Tages-Spanne:
$2.53
$2.6875
1-Wochen-Bereich:
$2.4801
$3.40
52-Wochen-Spanne:
$1.168
$3.8999
Medicinova Inc Stock (MNOV) Company Profile
Firmenname
Medicinova Inc
Sektor
Branche
Telefon
858-373-1500
Adresse
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Compare MNOV vs VRTX, REGN, MRNA, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
2.58 | 126.99M | 596.60K | -11.72M | -9.51M | -0.2386 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-03-10 | Eingeleitet | Maxim Group | Buy |
| 2019-03-25 | Fortgesetzt | B. Riley FBR | Buy |
| 2018-03-28 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-04-18 | Eingeleitet | Credit Suisse | Outperform |
| 2013-01-04 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-05-24 | Herabstufung | MLV & Co | Buy → Hold |
| 2011-10-18 | Bestätigt | MLV Capital | Buy |
| 2011-06-22 | Eingeleitet | Global Hunter Securities | Buy |
| 2010-05-12 | Eingeleitet | Wedbush | Outperform |
| 2008-11-12 | Bestätigt | Ladenburg Thalmann | Buy |
| 2008-05-15 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-07-09 | Eingeleitet | Punk, Ziegel & Co | Buy |
Alle ansehen
Medicinova Inc Aktie (MNOV) Neueste Nachrichten
MediciNova completes double-blind phase of ALS drug trial By Investing.com - Investing.com Canada
MediciNova completes double-blind phase of ALS drug trial - Investing.com
MediciNova Announces Last Patient, Last Visit in Double-Blind Portion of COMBAT-ALS Phase 2b/3 Trial of MN-166 for ALS - Quiver Quantitative
MediciNova Announces Completion of Last Patient, Last Visit - GlobeNewswire
MediciNova stock trades at USD 2.88 with Q2 cash at USD 25.4 million - AD HOC NEWS
MediciNova Inc (NASDAQ: MNOV) Share Price, MNOV Stock News, MNOV Share Price & Updates - kalkine.com.au
MediciNova, Inc.Common Stock (Nasdaq:MNOV) Price Chart - The Chronicle-Journal
Market Sentiment Around Loss-Making MediciNova, Inc. (NASDAQ:MNOV) - Moomoo
Biotech Stocks At 52-Week HighsMNOV +36%, PBLS +10%, ABCL +9%, HAE, NEO - RTTNews
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Roth MKM Initiates MediciNova(MNOV.US) With Buy Rating, Announces Target Price $6 - Moomoo
Roth/MKM initiates MediciNova stock with buy on ALS drug potential - Investing.com Nigeria
MediciNova, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (MNOV) - Traders Union
Can MediciNova's Upcoming MN-166 And MN-001 Readouts Change The Investment Narrative? - RTTNews
MNOV: Key clinical data from ALS and metabolic trials expected soon, with cash runway secured - TradingView
Medicinova at H.C. Wainwright conference: data, not financing, drives case - Investing.com India
MediciNova to Participate in Two Investor Conferences in September - GlobeNewswire
MediciNova stock gains as price moves above 200-day line - ad-hoc-news.de
MediciNova Ends Standby Equity Financing Agreement - TipRanks
MediciNova (MNOV) ends $30M stock-sale deal after tapping only a fraction of it - Stock Titan
MNOV Q2 2026 Earnings: Narrower-Than-Expected Loss of -$0.05 Per Share Highlights Cost DisciplineFree Cash Flow Trends - dars.gov.et
MediciNova Updates Executive Contracts, Enhancing Change-in-Control Protection - TipRanks
3 Promising Penny Stocks With Over $50M Market Cap - Sahm
Medicinova (MNOV) Outlook: Closes 8.57% Higher at $1.52 in the Latest Reading; Market Levels: $1.44 and $1.60 Define the Nearby Reference Levels in Latest TradingVolatility Smile - vinanet.vn
Medicinova (MNOV) Snapshot: Ends Higher by 1.84% at $1.39 at the Close; Key Range - vinanet.vn
Medicinova (MNOV) Financial Update: Profit Per Share Surpasses Its Benchmark in the Current Update; After Results: The Market Price Declines 2.90% at the CloseEPS Growth Rate - vinanet.vn
MediciNova, Inc. (NASDAQ:MNOV) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Form 8K MediciNova Inc For: 19 August By Investing.com - Investing.com Nigeria
MediciNova updates executive employment agreements for CEO and CMO By Investing.com - Investing.com South Africa
MediciNova updates executive employment agreements for CEO and CMO - Investing.com
FY2026 EPS Estimates for MediciNova Lowered by HC Wainwright - MarketBeat
FY2028 EPS Estimates for MediciNova Lowered by HC Wainwright - MarketBeat
Medicinova (MNOV) Holds Steady at $1.31 as Clinical-Stage Biotech Trades Within RangeWave Alternation - Vinanet
MediciNova (MNOV) Reports Q2 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
MediciNova (NASDAQ:MNOV) Announces Quarterly Earnings Results - MarketBeat
MediciNova Inc reports results for the quarter ended June 30Earnings Summary - TradingView
MediciNova: Q2 Earnings Snapshot - AOL.com
MNOV: Q2 2026 revenue grew and net loss narrowed, with cash reserves supporting operations into 2027 - TradingView
MNOV Q2'26 Earnings: EPS estimate is (0.06) USD - TradingView
MNOV Q1 2026 Earnings: Narrower-Than-Expected Loss, But Stock Slips 1.49%Post-Announcement Reaction - dars.gov.et
MediciNova Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
MNOV Q2'26 Earnings: revenue estimate is 75.00K USD - TradingView
MediciNova Inc (MNOV) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
MediciNova (MNOV) Projected to Release Earnings on Thursday - MarketBeat
MNOV Q1 2026 Earnings: Narrower-than-Expected Loss Underscores Operational DisciplineNon-GAAP Earnings - dars.gov.et
Medicinova (MNOV) Holds at $1.33 as Shares Dip 0.75% in Quiet Trading SessionVolume Profile - dars.gov.et
Price to book forward of MediciNova, Inc. – NASDAQ:MNOV - tradingview.com
Medicinova Inc (MNOV) Edges Higher on Modest Volume, Testing Key ResistanceUp Down Ratio - careplusvn.com
MNOV Q1 2026 Earnings: EPS Beat Driven by Reduced Operating Costs, Stock Declines 3%EPS Miss Report - vinanet.vn
MediciNova, Inc. Revenue Breakdown – NASDAQ:MNOV - TradingView
Finanzdaten der Medicinova Inc-Aktie (MNOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):